SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-012362
Filing Date
2024-03-21
Accepted
2024-03-21 07:30:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 mineralys-sx3march2024.htm S-3 569319
2 EX-FILING FEES mineralys-exhibit107xsx3.htm EX-FILING FEES 18106
3 EX-1.2 mineralys-exhibit12xsx3.htm EX-1.2 287070
4 EX-4.3 mineralys-exhibit43xsx3.htm EX-4.3 430262
5 EX-5.1 mineralys-exhibit51xsx3.htm EX-5.1 42414
6 EX-23.2 mineralys-exhibit232xsx3.htm EX-23.2 2421
7 image_0a.jpg GRAPHIC 12234
8 min_logoxprimaryxfullcolor.jpg GRAPHIC 594484
  Complete submission text file 0001628280-24-012362.txt   1969371
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278122 | Film No.: 24769442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)